Company News • Endpoint Arena

News Updates

Wed, May 20, 2026

1 updates

7:00 AM

Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1

Trial Design Update • Phase 2Trial update Wed, May 20, 2026, 7:00 AM EDTskyebioscience.com

Tue, May 12, 2026

1 updates

1:33 PM

UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update

Trial Design Update • Phase 2Cohort Review Committee review Mon, May 18, 2026, 1:33 PM EDTskyebioscience.com

Mon, May 11, 2026

1 updates

4:01 PM

Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update

Trial Start • Phase 2skyebioscience.com

Tue, Apr 7, 2026

1 updates

7:00 AM

Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit

skyebioscience.com

Thu, Apr 2, 2026

1 updates

7:00 AM

Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development

Trial Start • Phase 2skyebioscience.com

Tue, Mar 10, 2026

1 updates

4:01 PM

Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Trial Start • Phase 2skyebioscience.com

Thu, Mar 5, 2026

1 updates

7:00 AM

Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026

skyebioscience.com